CH675075A5 - - Google Patents

Download PDF

Info

Publication number
CH675075A5
CH675075A5 CH1007/88A CH100788A CH675075A5 CH 675075 A5 CH675075 A5 CH 675075A5 CH 1007/88 A CH1007/88 A CH 1007/88A CH 100788 A CH100788 A CH 100788A CH 675075 A5 CH675075 A5 CH 675075A5
Authority
CH
Switzerland
Prior art keywords
mass
fatty acids
selenium
algae
epa
Prior art date
Application number
CH1007/88A
Other languages
German (de)
English (en)
Inventor
Gyoergy Baktay
Peter-Nagy Dr Literati
Lajos Gyorgy Dr Nagy
Gyoergy Dr Blasko
Miklos Grosz
Janos Dr Palinkas
Maria Dr Boross
Miklos Dr Fabian
Erzsebet-Lics Pako-Teng
Laszlo Dr Bogdany
Gabor Nemeth
Original Assignee
Caola Kozmetikai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Caola Kozmetikai filed Critical Caola Kozmetikai
Publication of CH675075A5 publication Critical patent/CH675075A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CH1007/88A 1987-03-18 1988-03-17 CH675075A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU871173A HU204199B (en) 1987-03-18 1987-03-18 Process for producing pharmaceutical compositions containing unsaturated fatty acids and selenium as active components

Publications (1)

Publication Number Publication Date
CH675075A5 true CH675075A5 (xx) 1990-08-31

Family

ID=10953170

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1007/88A CH675075A5 (xx) 1987-03-18 1988-03-17

Country Status (24)

Country Link
JP (1) JPS6427A (xx)
CN (1) CN88101370A (xx)
AT (1) AT395818B (xx)
AU (1) AU610141B2 (xx)
BE (1) BE1002428A3 (xx)
CH (1) CH675075A5 (xx)
DD (1) DD280904A5 (xx)
DE (1) DE3809225A1 (xx)
DK (1) DK148788A (xx)
ES (1) ES2009569A6 (xx)
FI (1) FI881307A (xx)
FR (1) FR2612399B1 (xx)
GB (1) GB2203042B (xx)
GR (1) GR1000447B (xx)
HU (1) HU204199B (xx)
IL (1) IL85776A (xx)
IT (1) IT1216142B (xx)
LU (1) LU87169A1 (xx)
NL (1) NL8800693A (xx)
NO (1) NO881214L (xx)
PT (1) PT87017B (xx)
SE (1) SE8800988L (xx)
YU (1) YU55388A (xx)
ZA (1) ZA881957B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU210122B (en) * 1988-03-23 1995-02-28 Biorex Kutato Fejlesztoe Kft Process for production of composition against thromboembolytic conditions of circulating system and heart
DE3901048A1 (de) * 1989-01-14 1990-07-19 Chimicasa Gmbh Antikachectikum
GB9001121D0 (en) * 1990-01-18 1990-03-21 Efamol Holdings Efa compositions and therapy
JP2529756B2 (ja) * 1990-06-11 1996-09-04 三菱電機株式会社 リニアモ―タエレベ―タ―
US5302266A (en) * 1992-03-20 1994-04-12 International Business Machines Corporation Method and apparatus for filing high aspect patterns with metal
GB2363331B (en) * 2000-06-17 2003-02-05 Raymond Clifford Noble Supplement to enhance fertility
FR2816211B1 (fr) * 2000-11-08 2005-04-01 Brif Nouvelles compositions dietetiques et ou/cosmetiques pour ameliorer la secheresse des muqueuses
US20040076695A1 (en) 2002-07-08 2004-04-22 Advanced Vision Research EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia
WO2004071519A1 (fr) * 2003-01-14 2004-08-26 Bruneau Francois Micro-organismes photosynthetiques enrichis en molecules biologiquement actives, leurs procedes de preparation, et leurs utilisations
KR101235675B1 (ko) 2010-11-04 2013-02-21 한국식품연구원 ｐ-자일렌셀레노시아네이트를 유효성분으로 함유하는 비만 및 지질 관련 대사성 질환의 예방 및 치료용 조성물
CN107998227A (zh) * 2016-10-28 2018-05-08 新时代健康产业（集团）有限公司 一种保护心脏的保健品及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels

Also Published As

Publication number Publication date
IL85776A0 (en) 1988-09-30
LU87169A1 (fr) 1989-10-26
DK148788A (da) 1988-09-19
IL85776A (en) 1992-09-06
FI881307A0 (fi) 1988-03-18
ATA73788A (de) 1992-08-15
CN88101370A (zh) 1988-11-09
GR1000447B (el) 1992-07-30
JPS6427A (en) 1989-01-05
HU204199B (en) 1991-12-30
BE1002428A3 (fr) 1991-02-05
HUT52388A (en) 1990-07-28
SE8800988L (sv) 1988-09-19
PT87017A (pt) 1988-04-01
IT8819838A0 (it) 1988-03-18
AU610141B2 (en) 1991-05-16
DE3809225A1 (de) 1988-11-03
NO881214L (no) 1988-09-19
DD280904A5 (de) 1990-07-25
DK148788D0 (da) 1988-03-18
NO881214D0 (no) 1988-03-18
PT87017B (pt) 1992-06-30
FR2612399B1 (fr) 1991-03-29
GB2203042A (en) 1988-10-12
YU55388A (en) 1989-10-31
ES2009569A6 (es) 1989-10-01
GR880100170A (en) 1989-01-31
FI881307A (fi) 1988-09-19
ZA881957B (en) 1989-01-25
SE8800988D0 (sv) 1988-03-18
AU1326188A (en) 1988-09-22
IT1216142B (it) 1990-02-22
NL8800693A (nl) 1988-10-17
GB8806530D0 (en) 1988-04-20
AT395818B (de) 1993-03-25
GB2203042B (en) 1990-10-03
FR2612399A1 (fr) 1988-09-23

Similar Documents

Publication Publication Date Title
DE60208544T2 (de) Natürliche phenolische produkte und deren derivate zum schutz vor neurodegenerativen erkrankungen
DE69409969T2 (de) Salze der mehrfach ungesättigten fettsäuren und diese enthaltende pharmazeutischen zusammensetzungen
DE60022987T2 (de) Fettsäurezusammensetzung, die wenigstens 80 Gew.-% EPA und DHA enthält
DE2524355C2 (de) Tetrahydropyranderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4058594A (en) Immuno-suppressive agents
DE3850434T2 (de) Arzneimittel, diätetisches Produkt und hygienisches Produkt in Form einer pulverigen Zusammensetzung, erhalten durch Adsorption der Wirkstoffe auf einem schnellöslichen Zucker und Verfahren zur Herstellung dieser Zusammensetzung.
US3993775A (en) Immuno-suppressive agents
CH644267A5 (en) Pharmaceutical compositions containing (all-Z)-5,8,11,14,17-eicosapentaenoic acid or one of its pharmaceutically acceptable salts, esters or amides
DE3785667T2 (de) Zusatznahrung bzw. therapie für personen mit risiko oder in behandlung für arteriosklerotische vaskuläre, kardiovaskuläre und/oder thrombotische erkrankungen.
CH677732A5 (xx)
DE3438630A1 (de) Kombinierte fettsaeurezusammensetzung zur senkung des cholesterin- und triglycerid-blutspiegels
EP1174130A2 (de) Verwendung von Präparaten der Curcuma-Pflanzen
DE2749492C2 (de) Antithrombosemittel
AT395818B (de) Auf das herz-kreislauf-system wirkende arzneimittelpraeparate und verfahren zur herstellung derselben
DE69817334T2 (de) Kalkmaterial
EP0552657A1 (de) Verwendung von reiner Boswelliasäure
CH677863A5 (xx)
DE69015910T2 (de) Pharmazeutische Verwendung von Fettsäuren.
JPH0127A (ja) 心臓および心臓血管系に作用する薬剤並びにその製造方法
DE3739700A1 (de) Alpha-linolensaeure (18:3,omega 3) und/oder deren derivate enthaltende formulierungen, sowie verfahren zu ihrer herstellung und anwendung in ernaehrung und medizin
CH676929A5 (xx)
WO2000012071A2 (de) Pharmazeutisches und/oder diätetisches produkt
DE2535228A1 (de) Mikrokristallin 3-(alpha-acetonylbenzyl)-umbelliferon (rattengift), dessen zusammensetzung, verfahren der herstellung und verwendung
DE3317578A1 (de) Neue arzneimittelkombination und verfahren zu deren herstellung
DE2038836C3 (de) Arzneimittel

Legal Events

Date Code Title Description
PL Patent ceased